Texas Oncology, Memorial Hermann Memorial City, US Oncology Research-McKesson Specialty Health
Oncology
Dr. Frankie A. Holmes, MD
|
|
Give Review
Doctor Frankie A. Holmes, MD practices Oncology. He went to medical school at Virginia Commonwealth University School of Medicine. He received 3 awards: "Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Frankie Holmes has written publications. He has 16 publications published with PubMed. The lastest paper is: 'Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled,...' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast Cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled,...
- Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast Cancer: a single-group, open-label, phase 2 study.
- Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast Cancer.
- A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast Cancer.
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research...
- The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast Cancer.
- Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast Cancer: report of a Tamoxifen Exemestan...
- Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast Cancer.
- Pharmacogenomics of tamoxifen in a nutshell-and who broke the nutcracker?
- Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast Cancer undergoing adjuvant or neoadjuvant chemotherapy.
- Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast Cancer.
- The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable b...
- Filgrastim-mediated neutrophil recovery in patients with breast Cancer treated with docetaxel and doxorubicin.
- Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast Cancer: preliminary data of a prospective randomized trial.
- Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast Cancer with no evidence of disease.
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Blue Choice
- Cigna
- Commercial Insurance Company
- CoreSource
- Emblem Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- Guardian
- Health Alliance
- Medicare Advantage PFFS
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- MHealth Insured
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Old Surety Life Insurance CompanyMedicare MCR
- Principal Life
- Tricare
- Tufts Health Plans
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- Meaningful Use Stage 1 Certification
- Top MD
- Super Doctor
Education
-
University of Texas MD Anderson Cancer Center -
Hartford Hospital -
Virginia Commonwealth University School of Medicine
Drug Facts
| NPI NUMBER | 1336187897 | |
| NPPES Provider LastName | HOLMES | |
| NPPES Provider FirstName | FRANKIE | |
| NPPES Provider ZIPCode | 770242545 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 665.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 2.11 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336187897 |
| Last Name Of The Provider | HOLMES |
| First Name Of The Provider | FRANKIE |
| View All |
Similar Doctors
|
Dr. Nikesh Jasani, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. Theriault, DO |
|
Dr. Veena Chandrakar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Zarzour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna S. Zhukovsky, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Patrick Hwu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Amin M. Alousi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|